ArticleJournal of intensive care2024

Three-month outcomes and cost-effectiveness of interferon gamma-1b in critically ill patients: a secondary analysis of the PREV-HAP trial.

Marwan Bouras et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.